Fampridine Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Fampridine Market

Key Insight

The fampridine market was valued at USD 5.38 million in 2025 and is forecast to register a 7.3% CAGR between 2026 and 2036. In 2026, multiple sclerosis (walking improvement) holds 85.1% of application sales, powder represents 72.9% within the form segment and direct accounts for 71.3% of the sales channel category.

July 22, 2026

Anurag Sharma

250 Pages

Cite this Report

Fampridine Market

https://www.futuremarketinsights.com/reports/fampridine-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Merz Therapeutics
Viatris
Mylan
Teva
Actavis
Aurobindo Pharma
Accord Healthcare
Sun Pharma
Hikma Pharmaceuticals
Alkem Laboratories
Ascend Laboratories
CivicaScript

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Fampridine Market

Key Players

Similar Industry Reports